More Medicine, Sicker Children: The Numbers Nobody Puts on One Page

The paradox, measured

The United States spends about 17.8 percent of everything it produces on health care, roughly double the share of other wealthy countries, while using care at similar rates; the difference is prices, administration and pharmaceuticals [1]. What it buys is not longevity. Against 18 other high-income countries, US excess deaths rose from 346,166 a year in 1999 to 905,159 in 2022. More than half of the 2022 gap came from circulatory and metabolic disease, the conditions that grow in a body for decades before they kill it [2]. Every age bracket is in that gap. That is the whole thesis in two studies: the most medicated population on earth is the sickest among its peers, and the excess is not infection or accident. It is metabolism.

The children, by the numbers

Start with the youngest, because they have had the least time to earn a disease. Between 2016 and 2020, in a national survey of 174,551 US children, diagnosed anxiety rose 29 percent and depression 27 percent, while daily physical activity fell 18 percent [3]. Type 2 diabetes, a disease that did not exist in pediatrics a generation ago, rose 95 percent in prevalence among US children and adolescents between 2001 and 2017, and type 1 rose 45 percent [4]. Only 22 percent of US adolescents have no cardiometabolic risk factor at all, and even among those with a normal weight, only about one in three meet every marker of metabolic health [5]. By adulthood the figure is 12.2 percent [6]. Parent-reported autism reached 2.5 percent of US children in the 2016 national survey, with most of those children medicated or in treatment [7]. And the nutrient side is not separate from the disease side: children with obesity in the national nutrition survey eat about the same vitamin D as their peers but carry more than three times the odds of low blood levels, which is deficiency hiding inside abundance [8]. Sicker, younger, and short of the raw materials. That is the pattern the rest of this post tries to explain.

Young hearts: what is documented, and what is not

Here is where I will be exact, because the claim matters too much to overstate. Myocarditis after mRNA COVID-19 vaccination is documented, not disputed. In US surveillance of 354 million doses, confirmed myocarditis peaked at 105.9 cases per million second doses in males aged 16 to 17 [9]. A 2025 meta-analysis of ten adolescent studies found the risk concentrated in males after dose two, with the higher-dose product carrying roughly four times the rate of the lower one [10]. Systematic reviews describe most cases as mild and self-limiting, mostly after dose two in younger males [11]. What the published population data does not yet show is an across-the-board surge in youth heart attacks: sudden cardiac arrest in adults under 40 runs at one to two per 100,000 person-years in Western countries [12], and a 16-country European analysis found the excess mortality of 2020 and 2021 among 20-to-64-year-olds did not persist into 2023 and 2024 [13]. My position, stated as mine: a new technology was given to healthy teenagers who were at almost no risk from the disease, with a known and sex-specific cardiac signal, without the long follow-up any parent would want. Whether that becomes a population-scale cardiac story is not settled in the literature. The consent failure is settled. Nobody was told the number above before the needle.

The placebo question, and the courtroom

Two things people say about vaccines are half true, and the half matters. First: it is not true that no safety testing exists. Trials, animal studies, cohorts and surveillance all exist. It is true that many pivotal childhood vaccine trials compared the new product with another vaccine or an adjuvant-containing control rather than an inert saline placebo, and that no trial has tested the full childhood schedule as one exposure system against children who received none of it. The large COVID trials did use saline placebo for their short primary endpoint; the follow-up was months, not years. Second: the courts. Texas sued Pfizer in 2023 for misrepresenting the vaccine's efficacy; a federal judge dismissed it on federal-immunity grounds and the appeal is before the Fifth Circuit. Kansas sued in 2024 under its consumer-protection law and won the fight to keep the case in state court. A former trial-site director's False Claims Act suit alleging misconduct at Pfizer's trial sites was dismissed in 2023 and is on appeal. No court has ruled that fraud occurred. My argument, labeled as mine: a product line that enjoys federal immunity from injury suits, sells to every child by government schedule, and answers state attorneys general with immunity rather than data is a business model, not a public-health program.

The ingredients, and the arithmetic of a newborn

Two ingredients sit on the CDC's own hazardous-substance ranking, the ATSDR Substance Priority List: mercury at number 23 and aluminum at number 95. That list ranks substances by how often they turn up at contaminated sites, their toxicity and the chance of human exposure; it is not a list of the most toxic things on earth, and thimerosal left routine childhood vaccines two decades ago, surviving in some multi-dose flu vials. Aluminum did not leave. Now the arithmetic. A single pediatric dose of the hepatitis B vaccine given on the first day of life contains 0.25 milligrams of aluminum, by its own package insert. The FDA's rule for aluminum in intravenous nutrition warns that patients with immature or impaired kidneys, premature newborns specifically, who receive more than 4 to 5 micrograms per kilogram per day accumulate aluminum at levels linked to bone and nervous-system toxicity. A 3.5-kilogram newborn receiving 250 micrograms in one injection gets about 71 micrograms per kilogram that day, roughly fourteen times that threshold. Here is the other side, stated plainly: that FDA rule is written for continuous intravenous feeding, not muscle injection; the FDA's own pharmacokinetic model concludes that aluminum from the schedule and diet stays under its calculated limit because muscle-injected aluminum is absorbed slowly and cleared by the kidneys [14]; a Danish nationwide cohort found no association between cumulative vaccine aluminum and autoimmune, allergic or neurodevelopmental disorders, while noting small effects in rarer disorders could not be excluded [15]; and a 2026 review in Pediatrics reaches the same conclusion [16]. My reply, as mine: every one of those studies compares children who got aluminum with children who got slightly less aluminum. None of them is the study a parent is actually asking for, and a model is not a measurement in a newborn's brain. The dose-to-weight comparison stands as a question the field has answered with reassurance rather than with that study.

Follow the money, because the money follows nothing else

Why is this so hard to see clearly? Because the people producing the evidence are paid by the people selling the product. A systematic review of 75 studies found industry-sponsored drug and device trials more often reported favorable results and conclusions than independent ones, with the same rate of reported harms [17]. In nutrition it is worse: independent trials of unprocessed red meat reported unfavorable cardiovascular findings 73 percent of the time; industry-linked trials, 21 percent, nearly four times more likely to come out favorable [18]. Between 1999 and 2018 the pharmaceutical and health-product industry spent 4.7 billion dollars on federal lobbying and another 1.3 billion on campaign contributions [19]. In the country that spends the most, the spending itself is the largest industry, and its growth depends on a population that stays sick and treated. This is where I use a word some people will not like: when an industry knowingly profits from harm at population scale, one perspective is that it is a crime against humanity. That is my view. What the record supports without any label is narrower and bad enough: the incentives point toward more product, more procedure and more confusion, and the outcomes above are what those incentives produce.

The food and the products get the same free pass

The injection side of the ledger gets the attention. The daily side is bigger. In national survey data from 1999 to 2018, every 10 percent of calories from ultra-processed food raised the odds of metabolic syndrome, diabetes and cancer, and the association held even after adjusting for diet quality [20]. A 2026 review of 127 studies found consistent links between prenatal and childhood exposure to phthalates, bisphenols and pesticides and higher ADHD risk, with the gut as a shared pathway [21]. Food additives enter the American food supply under a self-affirmed "generally recognized as safe" process in which the manufacturer decides and need not tell the agency. Supplements are sold with structure-function claims that no regulator tests before the bottle ships, and yes, that includes products this site carries, which is why every one of them links to the studies rather than to a promise. The quick fix is the whole economy: a pill for the number, a bar for the hunger, a shot for the season, a subscription for the symptom. Nobody in that chain is paid to ask what the cell was missing.

It is not complicated: what a cell actually needs

Strip the terminology from every specialty and one picture is left. A cell senses its environment, exchanges what it needs for what it must get rid of, transforms fuel into energy, builds and repairs, maintains its boundaries and adapts to load. Nutrients in, oxygen in, signals in, waste out. Every chronic disease in this post is a failure somewhere on that loop: a nutrient that never arrived, a toxin that blocked the exchange, a signal drowned by noise, a waste product that could not leave. That is what The Holistic Hub is for. One place, plain language, the studies underneath, so a nurse's-eye view of the cell is available to anyone who was handed a diagnosis and a prescription and no explanation. My argument, and the reason this site exists: preventable metabolic disease is deficiency plus toxic load, measured in a lab you can read yourself and fixed at the plate before it is fixed at the pharmacy.

What to do with this

Measure before you medicate. The Lab Library explains about 200 markers in plain words, what moves them and what to eat to move them. The Diet Builder turns a deficiency into a grocery list. Meet Yourself is a free self-portrait for the week a diagnosis lands. Before any injection, for you or a child, read the insert, ask for the ingredient list and the control group used in its trial, and get the answer in writing. Ask what the number is for your age and sex, not the average. And remember the loop: nutrients, oxygen, signals, waste. If a plan does not touch one of those, it is managing a number, not restoring a cell.

• Pull your own labs and read them in the Lab Library before accepting a prescription for a number.
• Fix the two most common gaps first: minerals and vitamin D. They are measurable in one draw.
• Cut the ultra-processed share of the plate; the risk moves per 10 percent, so every swap counts.
• For any injection: insert, ingredients, control group, age-and-sex-specific numbers, in writing.
• Retest. A body that got its nutrients back shows it in the same markers within months.